Bernardini N - Search Results

1

Superoxide anion production by doxorubicin analogs in heart sarcosomes and by mitochondrial NADH dehydrogenase.

Gervasi PG, Agrillo MR, Lippi A, Bernardini N, Danesi R, Del Tacca M. Gervasi PG, et al. Among authors: bernardini n. Res Commun Chem Pathol Pharmacol. 1990 Jan;67(1):101-15. Res Commun Chem Pathol Pharmacol. 1990. PMID: 2158133

2

[The physiopathological aspects of the atrial natriuretic factor].

Agen C, Bernardini N, Blandizzi C, Danesi R, Del Tacca M. Agen C, et al. Among authors: bernardini n. Minerva Med. 1992 Apr;83(4):169-80. Minerva Med. 1992. PMID: 1315427 Review. Italian.

3

Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart.

Agen C, Sironi AM, Danesi R, Costa M, Bernardini N, Paparelli A, Della Torre P, Del Tacca M. Agen C, et al. Among authors: bernardini n. Toxicology. 1992 Nov 15;75(3):209-19. doi: 10.1016/0300-483x(92)90003-w. Toxicology. 1992. PMID: 1455430

4

Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Zaccaro L, Pieracci D, Malvaldi G, Del Tacca M. Danesi R, et al. Among authors: bernardini n. Cancer Chemother Pharmacol. 1992;29(4):261-5. doi: 10.1007/BF00685942. Cancer Chemother Pharmacol. 1992. PMID: 1472260

5

The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor beta 1 (TGF-beta 1).

Danesi R, Agen C, Bernardini N, Costa M, Del Tacca M. Danesi R, et al. Among authors: bernardini n. Pharmacol Res. 1992 Feb-Mar;25 Suppl 1:17-8. doi: 10.1016/1043-6618(92)90519-h. Pharmacol Res. 1992. PMID: 1508796 No abstract available.

6

Doxorubicin cardiotoxicity is associated with alterations of plasma levels of atrial natriuretic factor.

Bernardini N, Agen C, Favilla S, Danesi R, Del Tacca M. Bernardini N, et al. J Endocrinol Invest. 1992 Feb;15(2):79-84. doi: 10.1007/BF03348668. J Endocrinol Invest. 1992. PMID: 1533234

7

Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.

Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Among authors: bernardini n. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601

8

Comparative activity of doxorubicin and its major metabolite, doxorubicinol, on V79/AP4 fibroblasts: a morphofunctional study.

Bernardini N, Giannessi F, Bianchi F, Dolfi A, Lupetti M, Zaccaro L, Malvaldi G, Del Tacca M. Bernardini N, et al. Exp Mol Pathol. 1991 Dec;55(3):238-50. doi: 10.1016/0014-4800(91)90004-h. Exp Mol Pathol. 1991. PMID: 1748213

9

Cardiotoxicity and cytotoxicity of the anthracycline analog 4'-deoxy-4'-iodo-doxorubicin.

Danesi R, Bernardini N, Agen C, Costa M, Macchiarini P, Della Torre P, Del Tacca M. Danesi R, et al. Among authors: bernardini n. Toxicology. 1991;70(2):243-53. doi: 10.1016/0300-483x(91)90050-b. Toxicology. 1991. PMID: 1763418

10

[The clinical efficacy of roxithromycin in patients with acute odontogenic infections].

Panattoni E, Marcucci M, Gabriele M, Natale ML, Blandizzi C, Bernardini N, Del Tacca M. Panattoni E, et al. Among authors: bernardini n. Minerva Stomatol. 1991 Apr;40(4):273-6. Minerva Stomatol. 1991. PMID: 1896005 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters